$NSLR

Neostellar Cap earnings missed by $0.65, revenue fell short of estimates

Neostellar Cap (NSLR) reported Q3 EPS of -$0.80, missing estimates by $0.65, with revenue at $271.81K, below the $732K consensus. The stock is down 38.54% in 3 months and 41.06% in 12 months. InvestingPro rates its financial health as 'fair performance'.

Original reporting
Published Nov 4, 2026, 12:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NSLR
Bearish
high confidence
Mentioned
$NSLR
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NSLRBearishMed
01

Why it matters

The earnings miss is likely to drive the stock lower in the short term.

02

Market read

Earnings disappointment for a micro‑cap may affect niche investors but has limited broader market impact.

03

What to watch

Potential upcoming product launches or cost‑cutting measures not disclosed yet.

Relevance 6/10Novelty 6/10Timing: after-hours reaction

Background

Neostellar Cap (NASDAQ: NSLR) reported Q3 results that fell short of analyst expectations.

Company-level read

Ticker impact

$NSLRBearishHigh confidence
Context

Q3 EPS of -$0.80 missed estimate by $0.65 and revenue of $271.81K fell short of $732K consensus.

Expected impact

downward pressure as investors price in the miss

Evidence & confidence

The company posted a material earnings miss with both EPS and revenue well below expectations, prompting negative sentiment.

Market effects

Micro‑cap tech sector may see modest pullback as earnings disappointment spreads.

Limited to U.S. micro‑cap investors; no broader regional effect.

Low global relevance due to small company size.

Counterpoint

If the miss is viewed as a temporary setback, the stock could be a cheap buy on the dip.

Key entities

  • Neostellar Cap

    Micro‑cap listed on NASDAQ.

Related articles

$NSLRMed

Neostellar Capital Q3 Earnings Call Highlights

Neostellar Capital (NSLR) reported Q3 investments in AI-related companies, including OpenAI, ClickHouse, and TensorWave. OpenAI's valuation was noted at $852B, with $50B annualized revenue. WHOOP's valuation was adjusted, and Neostellar plans to monetize part of its investment. The company exited several investments, including Learneo and Aventine Property Group, with realized losses. Neostellar ended the quarter with $42.2M in liquid assets and plans to repay debt by year-end.

$NSLRMed

Neostellar Capital Corp. Reports Third Quarter 2026 Financial Results

Neostellar Capital Corp. (NSLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Neostellar Capital Corp. Reports Third Quarter 2026 Financial Results Net Asset Value of $12.64 Per Share as of September 30, 2026 Board of Directors Approves Extension of Share Repurchase Program NEW YORK, NY, November 3, 2026 (GLOBE NEWSWIRE) – Neostellar Capital C

$NSLRLow

Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update

Neostellar Capital Corp. (NSLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update Net Asset Value Expected to be $12.25 to $12.75 Per Share NEW YORK, NY, October 5, 2026 (GLOBE NEWSWIRE) – Neostellar Capital Corp. (“Neostellar Capital”, the “Company”, “we

$NSLRMed

Neostellar Capital Corp. Reports Second Quarter 2026 Financial Results

Neostellar Capital Corp. (NSLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Neostellar Capital Corp. Reports Second Quarter 2026 Financial Results An Affiliate of Magnetar Invested $20.0 Million in Neostellar Through a Redeemable Promissory Note Subsequent to Quarter-End Net Asset Value of $13.44 Per Share as of June 30, 2026 NEW YORK, NY, A

$SOPHMed

Sophia Genetics SA (SOPH) (Q3 2026) Earnings Call Highlights: Revenue Surges 25% with Strong

Sophia Genetics SA (SOPH) reported a 25% revenue surge in Q3 2026. CEO Ross Muken expects continued growth in 2027, driven by strong product momentum and a high backlog of customers. The company is investing in medical affairs to drive adoption and has secured notable biopharma collaborations, including with AstraZeneca. CFO George Cardoza emphasized profitability commitments and conservative guidance.

$ONHighAI 8/10

Onsemi delays auto restocking as AI sales jump 175%

Onsemi (ON) reported Q3 revenue of $1.72B, up 11% YoY, with AI data center revenue jumping 175% to $180M. The company is prioritizing AI and industrial chip supply, delaying some automotive restocking orders. Onsemi acquired Ferric for $600M to expand AI power management, raising its 2030 AI revenue target to over $3B. Shares rose 4.78% post-earnings.